Family-based treatment for adolescent anorexia nervosa: What happens to rates of comorbid diagnoses?
adolescents
anorexia nervosa
family-based treatment
psychiatric comorbidity
recovery
Journal
European eating disorders review : the journal of the Eating Disorders Association
ISSN: 1099-0968
Titre abrégé: Eur Eat Disord Rev
Pays: England
ID NLM: 9436977
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
26
07
2019
revised:
26
11
2019
accepted:
11
01
2020
pubmed:
30
1
2020
medline:
25
11
2020
entrez:
30
1
2020
Statut:
ppublish
Résumé
Rates of psychiatric comorbidity are elevated in adolescents with anorexia nervosa, but little is known about how psychiatric comorbidity changes following family-based treatment (FBT). Adolescents with anorexia nervosa (N = 107) enrolled in a randomized controlled trial comparing two forms of FBT completed the Mini International Neuropsychiatric Interview for Children and Adolescents at baseline and end of treatment. Analyses tested whether baseline comorbid diagnoses predicted the presence of comorbid diagnoses at end of treatment and if baseline eating disorder psychopathology impacted this association. Rates of comorbid diagnoses decreased from 54% at baseline to 26% at end of treatment. Logistic regression analyses indicated that individuals with multiple comorbid diagnoses at baseline were more likely to meet criteria for a comorbid condition at end of treatment (b = 2.00, p < .05). Individuals with reported psychotropic medication use were less likely to meet criteria for a comorbid condition at end of treatment (b = -1.63, p = .04). Diagnostic rates for major depressive disorder, generalized anxiety disorder, and panic disorder/agoraphobia decreased following FBT. Findings suggest that FBT for adolescent anorexia nervosa may aid in the resolution of some co-occurring psychiatric diagnoses. Continued research is needed to understand factors contributing to comorbid symptom improvement throughout treatment.
Identifiants
pubmed: 31995262
doi: 10.1002/erv.2725
pmc: PMC7192783
mid: NIHMS1559956
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
351-357Subventions
Organisme : NIMH NIH HHS
ID : R01 MH118261
Pays : United States
Organisme : Baker Foundation
Pays : International
Organisme : Baker Foundation (Australia)
Pays : International
Organisme : Victorian Government
Pays : International
Organisme : NIMH NIH HHS
ID : T32 MH018261
Pays : United States
Informations de copyright
© 2020 John Wiley & Sons, Ltd and Eating Disorders Association.
Références
Behav Res Ther. 2014 May;56:1-6
pubmed: 24632109
Eur Eat Disord Rev. 2017 Nov;25(6):432-450
pubmed: 28967161
Br J Psychiatry. 2006 Nov;189:428-32
pubmed: 17077433
Arch Gen Psychiatry. 1997 Nov;54(11):1025-30
pubmed: 9366659
J Clin Psychiatry. 2010 Mar;71(3):313-26
pubmed: 20331933
Int J Eat Disord. 2017 Nov;50(11):1323-1327
pubmed: 28913833
J Child Psychol Psychiatry. 2001 Jul;42(5):603-12
pubmed: 11464965
Int J Eat Disord. 2007 Nov;40 Suppl:S46-51
pubmed: 17610248
J Nerv Ment Dis. 2014 Oct;202(10):759-62
pubmed: 25265267
Nord J Psychiatry. 2010;64(1):32-9
pubmed: 19883196
Eur Child Adolesc Psychiatry. 2017 Aug;26(8):969-978
pubmed: 28258321
J Am Acad Child Adolesc Psychiatry. 2016 Aug;55(8):683-92
pubmed: 27453082
Eur Eat Disord Rev. 2014 Jan;22(1):39-44
pubmed: 24027221
J Adolesc Health. 2015 Jul;57(1):66-72
pubmed: 26095410
J Psychiatr Res. 2005 May;39(3):303-10
pubmed: 15725429
Int J Eat Disord. 2006 Nov;39(7):587-9
pubmed: 16941630
Biol Psychiatry. 2001 Apr 1;49(7):644-52
pubmed: 11297722
Eur Eat Disord Rev. 2012 Jan;20(1):e1-16
pubmed: 22223393
Arch Gen Psychiatry. 2010 Oct;67(10):1025-32
pubmed: 20921118
Arch Gen Psychiatry. 1987 Dec;44(12):1047-56
pubmed: 3318754
Psychopathology. 2008;41(5):307-12
pubmed: 18635933